MAPK8IP3
Basic information
Region (hg38): 16:1706166-1770351
Links
Phenotypes
GenCC
Source:
- neurodevelopmental disorder with or without variable brain abnormalities; NEDBA (Strong), mode of inheritance: AD
- neurodevelopmental disorder with or without variable brain abnormalities; NEDBA (Strong), mode of inheritance: AD
- neurodevelopmental disorder with or without variable brain abnormalities; NEDBA (Strong), mode of inheritance: AD
- neurodevelopmental disorder with or without variable brain abnormalities; NEDBA (Definitive), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Neurodevelopmental disorder with or without variable brain abnormalities | AD | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Craniofacial; Musculoskeletal; Neurologic | 30612693; 30945334 |
ClinVar
This is a list of variants' phenotypes submitted to
- Neurodevelopmental disorder with or without variable brain abnormalities; NEDBA (1 variants)
- Inborn genetic diseases (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MAPK8IP3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 36 | 15 | 52 | |||
missense | 150 | 27 | 185 | |||
nonsense | 6 | |||||
start loss | 0 | |||||
frameshift | 4 | |||||
inframe indel | 2 | |||||
splice donor/acceptor (+/-2bp) | 5 | |||||
splice region | 5 | 12 | 1 | 18 | ||
non coding | 10 | 12 | ||||
Total | 2 | 11 | 161 | 65 | 27 |
Variants in MAPK8IP3
This is a list of pathogenic ClinVar variants found in the MAPK8IP3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
16-1706348-G-A | MAPK8IP3-related disorder | Likely benign (Jul 01, 2024) | ||
16-1706354-G-T | Inborn genetic diseases | Uncertain significance (Oct 26, 2022) | ||
16-1706363-G-T | Inborn genetic diseases | Uncertain significance (Dec 19, 2019) | ||
16-1706378-G-A | MAPK8IP3-related disorder | Benign (Dec 02, 2019) | ||
16-1706386-A-G | Uncertain significance (Nov 16, 2019) | |||
16-1706387-G-C | not specified | Uncertain significance (May 02, 2024) | ||
16-1706401-C-A | Inborn genetic diseases | Uncertain significance (May 07, 2024) | ||
16-1706402-CG-C | Neurodevelopmental disorder with or without variable brain abnormalities; NEDBA • Inborn genetic diseases | Likely pathogenic (Jul 23, 2019) | ||
16-1706405-C-T | MAPK8IP3-related disorder | Benign (Dec 31, 2019) | ||
16-1706414-G-A | MAPK8IP3-related disorder | Uncertain significance (Jun 20, 2023) | ||
16-1706418-G-T | Neurodevelopmental disorder with or without variable brain abnormalities; NEDBA | Likely pathogenic (Oct 02, 2019) | ||
16-1706450-C-G | MAPK8IP3-related disorder • Neurodevelopmental disorder with or without variable brain abnormalities; NEDBA | Likely pathogenic (Oct 02, 2019) | ||
16-1706506-T-A | Neurodevelopmental disorder with or without variable brain abnormalities; NEDBA | Likely pathogenic (Aug 18, 2023) | ||
16-1706552-C-A | Uncertain significance (Nov 10, 2022) | |||
16-1706574-G-A | Developmental disorder | Uncertain significance (Dec 17, 2021) | ||
16-1706620-A-G | Neurodevelopmental disorder with or without variable brain abnormalities; NEDBA | Likely pathogenic (Feb 07, 2019) | ||
16-1706634-G-T | Inborn genetic diseases | Uncertain significance (Jun 16, 2024) | ||
16-1706658-G-A | Neurodevelopmental disorder with or without variable brain abnormalities; NEDBA | Likely pathogenic (May 06, 2021) | ||
16-1724612-A-G | Uncertain significance (Jan 09, 2023) | |||
16-1724625-C-T | MAPK8IP3-related disorder | Benign (Nov 01, 2019) | ||
16-1724626-G-A | Uncertain significance (Jan 17, 2020) | |||
16-1724639-G-A | Neurodevelopmental disorder with or without variable brain abnormalities; NEDBA | Uncertain significance (-) | ||
16-1729162-C-G | Uncertain significance (Jun 22, 2021) | |||
16-1729180-A-T | not specified | Uncertain significance (Jun 03, 2022) | ||
16-1729187-C-G | Likely benign (Apr 01, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MAPK8IP3 | protein_coding | protein_coding | ENST00000250894 | 32 | 64135 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 2.99e-8 | 124732 | 0 | 48 | 124780 | 0.000192 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.88 | 663 | 908 | 0.731 | 0.0000620 | 8685 |
Missense in Polyphen | 133 | 288.78 | 0.46056 | 2743 | ||
Synonymous | -2.54 | 453 | 389 | 1.16 | 0.0000296 | 2622 |
Loss of Function | 7.19 | 5 | 69.9 | 0.0715 | 0.00000340 | 756 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000285 | 0.000284 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000603 | 0.0000556 |
Finnish | 0.000140 | 0.000139 |
European (Non-Finnish) | 0.000333 | 0.000327 |
Middle Eastern | 0.0000603 | 0.0000556 |
South Asian | 0.00 | 0.00 |
Other | 0.000178 | 0.000165 |
dbNSFP
Source:
- Function
- FUNCTION: The JNK-interacting protein (JIP) group of scaffold proteins selectively mediates JNK signaling by aggregating specific components of the MAPK cascade to form a functional JNK signaling module (PubMed:12189133). May function as a regulator of vesicle transport, through interactions with the JNK-signaling components and motor proteins (By similarity). Promotes neuronal axon elongation in a kinesin- and JNK-dependent manner. Activates cofilin at axon tips via local activation of JNK, thereby regulating filopodial dynamics and enhancing axon elongation. Its binding to kinesin heavy chains (KHC), promotes kinesin-1 motility along microtubules and is essential for axon elongation and regeneration. Regulates cortical neuronal migration by mediating NTRK2/TRKB anterograde axonal transport during brain development (By similarity). Acts as an adapter that bridges the interaction between NTRK2/TRKB and KLC1 and drives NTRK2/TRKB axonal but not dendritic anterograde transport, which is essential for subsequent BDNF-triggered signaling and filopodia formation (PubMed:21775604). {ECO:0000250|UniProtKB:Q9ESN9, ECO:0000269|PubMed:12189133, ECO:0000269|PubMed:21775604}.;
- Pathway
- MAPK signaling pathway - Homo sapiens (human);EGF-Ncore;MAPK Signaling Pathway;Arf6 trafficking events;Signaling events mediated by focal adhesion kinase
(Consensus)
Recessive Scores
- pRec
- 0.189
Intolerance Scores
- loftool
- 0.0583
- rvis_EVS
- -2.65
- rvis_percentile_EVS
- 0.77
Haploinsufficiency Scores
- pHI
- 0.318
- hipred
- Y
- hipred_score
- 0.783
- ghis
- 0.694
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.959
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Mapk8ip3
- Phenotype
- homeostasis/metabolism phenotype; cellular phenotype; respiratory system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); vision/eye phenotype;
Zebrafish Information Network
- Gene name
- mapk8ip3
- Affected structure
- posterior lateral line
- Phenotype tag
- abnormal
- Phenotype quality
- swollen
Gene ontology
- Biological process
- activation of JUN kinase activity;vesicle-mediated transport;axon regeneration;regulation of JNK cascade;axon development;anterograde axonal protein transport
- Cellular component
- Golgi membrane;cytoplasm;axon;dendrite;growth cone;cytoplasmic vesicle;cell body;perinuclear region of cytoplasm;axon cytoplasm
- Molecular function
- MAP-kinase scaffold activity;protein binding;JUN kinase binding;kinesin binding;receptor signaling complex scaffold activity